160 related articles for article (PubMed ID: 15696597)
1. Structure-aided optimization of kinase inhibitors derived from alsterpaullone.
Kunick C; Zeng Z; Gussio R; Zaharevitz D; Leost M; Totzke F; Schächtele C; Kubbutat MH; Meijer L; Lemcke T
Chembiochem; 2005 Mar; 6(3):541-9. PubMed ID: 15696597
[TBL] [Abstract][Full Text] [Related]
2. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity.
Schultz C; Link A; Leost M; Zaharevitz DW; Gussio R; Sausville EA; Meijer L; Kunick C
J Med Chem; 1999 Jul; 42(15):2909-19. PubMed ID: 10425100
[TBL] [Abstract][Full Text] [Related]
3. CDK1-inhibitory activity of paullones depends on electronic properties of 9-substituents.
Pies T; Schaper KJ; Leost M; Zaharevitz DW; Gussio R; Meijer L; Kunicke C
Arch Pharm (Weinheim); 2004 Sep; 337(9):486-92. PubMed ID: 15362121
[TBL] [Abstract][Full Text] [Related]
4. Semi-empirical calculations on paullones, a promising class of cyclin-dependent kinase inhibitors.
Sharma PS; Tyagi R; Sharma R
Indian J Biochem Biophys; 2008 Dec; 45(6):416-20. PubMed ID: 19239129
[TBL] [Abstract][Full Text] [Related]
5. Imidazo[2,1 -b]thiazolylmethylene- and indolylmethylene-2-indolinones: a new class of cyclin-dependent kinase inhibitors. Design, synthesis, and CDK1/cyclin B inhibition.
Andreani A; Cavalli A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Recanatini M; Garnier M; Meijer L
Anticancer Drug Des; 2000 Dec; 15(6):447-52. PubMed ID: 11716438
[TBL] [Abstract][Full Text] [Related]
6. Identification of 2-anilino-9-methoxy-5,7-dihydro-6H-pyrimido[5,4-d][1]benzazepin-6-ones as dual PLK1/VEGF-R2 kinase inhibitor chemotypes by structure-based lead generation.
Egert-Schmidt AM; Dreher J; Dunkel U; Kohfeld S; Preu L; Weber H; Ehlert JE; Mutschler B; Totzke F; Schächtele C; Kubbutat MH; Baumann K; Kunick C
J Med Chem; 2010 Mar; 53(6):2433-42. PubMed ID: 20170163
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2-amino-4-(7-azaindol-3-yl)pyrimidines as cyclin dependent kinase 1 (CDK1) inhibitors.
Huang S; Li R; Connolly PJ; Emanuel S; Middleton SA
Bioorg Med Chem Lett; 2006 Sep; 16(18):4818-21. PubMed ID: 16870444
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullones.
Kunick C; Lauenroth K; Wieking K; Xie X; Schultz C; Gussio R; Zaharevitz D; Leost M; Meijer L; Weber A; Jørgensen FS; Lemcke T
J Med Chem; 2004 Jan; 47(1):22-36. PubMed ID: 14695817
[TBL] [Abstract][Full Text] [Related]
10. Homology model of the CDK1/cyclin B complex.
McGrath CF; Pattabiraman N; Kellogg GE; Lemcke T; Kunick C; Sausville EA; Zaharevitz DW; Gussio R
J Biomol Struct Dyn; 2005 Apr; 22(5):493-502. PubMed ID: 15702922
[TBL] [Abstract][Full Text] [Related]
11. Pyrrolo[2,3-a]carbazoles as potential cyclin dependent kinase 1 (CDK1) Inhibitors. Synthesis, biological evaluation, and binding mode through docking simulations.
Fousteris MA; Papakyriakou A; Koutsourea A; Manioudaki M; Lampropoulou E; Papadimitriou E; Spyroulias GA; Nikolaropoulos SS
J Med Chem; 2008 Feb; 51(4):1048-52. PubMed ID: 18232654
[TBL] [Abstract][Full Text] [Related]
12. Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structure.
Kawanishi N; Sugimoto T; Shibata J; Nakamura K; Masutani K; Ikuta M; Hirai H
Bioorg Med Chem Lett; 2006 Oct; 16(19):5122-6. PubMed ID: 16876403
[TBL] [Abstract][Full Text] [Related]
13. N-(indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studies.
Raffa D; Maggio B; Cascioferro S; Raimondi MV; Daidone G; Plescia S; Schillaci D; Cusimano MG; Titone L; Colomba C; Tolomeo M
Arch Pharm (Weinheim); 2009 May; 342(5):265-73. PubMed ID: 19415659
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 5-substituted indirubins as protein kinases inhibitors.
Beauchard A; Ferandin Y; Frère S; Lozach O; Blairvacq M; Meijer L; Thiéry V; Besson T
Bioorg Med Chem; 2006 Sep; 14(18):6434-43. PubMed ID: 16759872
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases.
Nishiguchi GA; Atallah G; Bellamacina C; Burger MT; Ding Y; Feucht PH; Garcia PD; Han W; Klivansky L; Lindvall M
Bioorg Med Chem Lett; 2011 Nov; 21(21):6366-9. PubMed ID: 21945284
[TBL] [Abstract][Full Text] [Related]
16. In-vitro antiproliferative activities and kinase inhibitory potencies of glycosyl-isoindigo derivatives.
Sassatelli M; Bouchikhi F; Aboab B; Anizon F; Fabbro D; Prudhomme M; Moreau P
Anticancer Drugs; 2007 Oct; 18(9):1069-74. PubMed ID: 17704657
[TBL] [Abstract][Full Text] [Related]
17. Nitrogen-containing flavonoids as CDK1/Cyclin B inhibitors: design, synthesis, and biological evaluation.
Liu T; Xu Z; He Q; Chen Y; Yang B; Hu Y
Bioorg Med Chem Lett; 2007 Jan; 17(1):278-81. PubMed ID: 17085048
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.
Nie Z; Perretta C; Erickson P; Margosiak S; Almassy R; Lu J; Averill A; Yager KM; Chu S
Bioorg Med Chem Lett; 2007 Aug; 17(15):4191-5. PubMed ID: 17540560
[TBL] [Abstract][Full Text] [Related]
19. Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.
Prudent R; Moucadel V; Laudet B; Barette C; Lafanechère L; Hasenknopf B; Li J; Bareyt S; Lacôte E; Thorimbert S; Malacria M; Gouzerh P; Cochet C
Chem Biol; 2008 Jul; 15(7):683-92. PubMed ID: 18635005
[TBL] [Abstract][Full Text] [Related]
20. Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR.
Richardson CM; Williamson DS; Parratt MJ; Borgognoni J; Cansfield AD; Dokurno P; Francis GL; Howes R; Moore JD; Murray JB; Robertson A; Surgenor AE; Torrance CJ
Bioorg Med Chem Lett; 2006 Mar; 16(5):1353-7. PubMed ID: 16325401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
